CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科学试剂-MedChemExpress_第1页
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科学试剂-MedChemExpress_第2页
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科学试剂-MedChemExpress_第3页
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemECDDO-EACat. No.: HY-12213CAS No.: 932730-51-3Synonyms: CDDO ethyl amide; TP319; RTA 405分式: CHNO分量: 518.73作靶点: Keap1-Nrf2作通路: NF-B储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 34 mg/mL (65

2、.54 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.9278 mL 9.6389 mL 19.2779 mL5 mM 0.3856 mL 1.9278 mL 3.8556 mL10 mM 0.1928 mL 0.9639 mL 1.9278 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠

3、性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (4.82 mM); Suspended solution; Need ultrasonic2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (4.82 mM); Clear solution1/3 Master o

4、f Small Molecules 您边的抑制剂师www.MedChemE3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (4.82 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 CDDO-EA种 NF-E2 相关因 2 /抗氧化反应元件 (Nrf2/ARE) 激活剂。IC50 & Target Nrf2/ARE 1体外研究 CDDO-EA potently activates Nrf2/ARE in a cell culture model of ALS and in the G93A S

5、OD1 mouse model ofALS 1. CDDO-EA is a potent inducer of apoptosis in A549 lung cancer cells, as shown both by PARPcleavage and Annexin staining. CDDO-EA is more potent than CDDO itself as inducers of heme oxygenase-1 (HO-1). In RAW264.7 macrophage-like cells, CDDO-EA is 7-fold more potent than CDDO

6、as suppressorsof the ability of IFN- to induce iNOS 2.体内研究 The survival analysis shows that G93A mice treated with CDDO-EA, compared to G93A littermate controls,lives significantly longer. CDDO-EA treatment increases the life-span by 20.6 days from 124.053.7 days to144.728.1 days (16.6%) (p 1.PROTOC

7、OLCell Assay 1 Wild-type and Nrf2/ mouse embryonic fibroblasts are pre-treated with CDDO-EA or CDDO-TFEA atvarious concentrations (1, 10 and 100 nM in DMSO) for 18 hours and incubated with 2,7-Dichlorodihydrofluorecein diacetate (H2DCFDA) for 30 min. Cells are challenged with 250 M tBHP for 15-30min

8、 and the mean fluorescence intensity for 10,000 cells is analyzed by FACSan flow cytometry using a480-nm excitation wavelength and a 525-nm emission wavelength 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 G93A SOD1 tra

9、nsgenic familial ALS mice (high copy number) B6SJL background strain (G93A SOD1,B6SJL-TgGur1) are used. G93A transgenic mice are assigned randomly to the control (vehicle, mouse chawonly) and to mouse chaw containing either CDDO-EA or CDDO-TFEA (400 mg/kg of food, n=30 in bothgroups). This dose corr

10、esponds to about 80 mg/kg body weight/day, assuming each mouse consumes 5grams of food per day. We found mice can tolerate this dose. Treatments started at two different timeregimens: 1) “Early” at 30 days of age, about two months prior to symptom onset; 2) “At Onset” from theonset of the phenotype

11、(80-90 days of age). A diet consisting of either 400 mg of CDDO-TFEA per kg of foodor 400 mg of CDDO-EA per kg of food, and a control lab diet, are prepared by Purina.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 J Cell Mol Med. 2019 Jun 2

12、1.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemESee more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Neymotin A, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model ofamyotrophic lateral sclerosis. Free Radic Biol Med. 2011 Jul 1;51(1):88-96.2. Liby K, et al. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate inA/J mice. Cancer Res. 2007 Mar 15;67(6):2414-9.McePdfHeigh

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论